European equities traded in the US as American depositary receipts were treading water late Friday morning, edging 0.055% higher to 1,351.69 on the S&P Europe Select ADR Index, which has gained 1.4% for the week.
From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which rose 4.4% and 2.3% respectively. They were followed by 3D printer company Materialise (MTLS) and pharmaceutical company Novo Nordisk (NVO), which were up 1.9% and 1.7% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which fell 4% and 3.1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and oil and gas company Eni (E), which were down 2.4% and 0.8% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which advanced 9.2% and 3% respectively. They were followed by software firm Endava (DAVA) and pharmaceutical company Silence Therapeutics (SLN), which increased by 4.1% and 2.5% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which dropped 10% and 1.5% respectively. They were followed by oil and gas companies BP (BP) and Shell (SHEL), which lost 1.4% and 1.3% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。